drugset
drugset / Trial / NCT04798209

A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-777991 in Healthy Subjects

NCT04798209 ↗

Phase 1 Completed 70 enrolled Idorsia Pharmaceuticals Ltd.
RandomizedSequentialQuadruple-blindOther

Summary

A study to examine the safety, tolerability, and pharmacokinetics of single- and multiple-ascending doses of ACT-777991 in healthy subjects.

Timeline

Start
2021-01-29
Primary completion
2022-01-26
Completion
2022-05-21

Drugs

EvaluationDrugModalityDoseRoute
Subject 14C-ACT-777991 Unknown — Intravenous
Subject ACT-777991 Unknown — Oral

Indications

No indication recorded.